Learn more

MICRO LABS LTD

Overview
  • Total Patents
    55
  • GoodIP Patent Rank
    173,311
  • Filing trend
    ⇩ 100.0%
About

MICRO LABS LTD has a total of 55 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are QURETECH BIO AB, Shenzhen zhijun pharmaceutical co ltd and KING CLIFFORD RILEY.

Patent filings per year

Chart showing MICRO LABS LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Kshirsagar Rajesh 37
#2 Kamble Pravin 18
#3 Shinde Ganesh 16
#4 Mundade Sachin 15
#5 Mudda Sm 14
#6 Kadam Chandrashekar 12
#7 Jain Sachin 7
#8 Mudda S M 7
#9 Dhanure Shivanand 6
#10 Mandpe Pankaj S 5

Latest patents

Publication Filing date Title
WO2021001713A1 Process for the preparation of (s)-netarsudil, its salts & polymorphs
WO2018042393A1 Novel process for the preparation of brivaracetam
WO2016166733A1 A process for preparing a pharmaceutical composition comprising rivaroxaban
WO2016120746A1 A pharmaceutical composition comprising roflumilast
WO2015173779A1 Process for the preparation of teneligliptin and its novel intermediates
US2015119371A1 Topical pharmaceutical compositions of antibiotics and steroidal anti inflammatory agents
EP2749556A1 An improved process for the preparation of pure cyamemazine and salts thereof
WO2014002011A1 Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof
WO2013179253A1 Fixed dose combination comprising nsaid and steroidal anti-inflammatory agent for treating post operative ocular inflammation
WO2013168032A1 Pharmaceutical compositions comprising rasagiline
WO2013065029A1 Fixed dose combination containing moxifloxacin and prednisolone for treatment of ocular infections
WO2013068876A1 Methods and compositions for treating ocular allergy
WO2013061269A1 Combinations of loteprednol and olopatadine for the treatment of ocular allergies
WO2013057569A2 Extended release pharmaceutical composition containing amoxicillin and clavulanic acid
WO2013054178A2 Extended release pharmaceutical compositions containing carbamazepine
WO2014009767A1 An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamide (z) derivatives, their isomers and salts
US2013034605A1 Extended release pharmaceutical compositions containing paliperidone
WO2012014052A2 Novel coated extended release pharmaceutical compositions containing paliperidone
WO2011161504A1 Extended release formulations containing darifenacin or pharmaceutically acceptable salts thereof
US2011159092A1 Extended release pharmaceutical composition comprising linezolid and process for preparing the same